E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers Q > Headlines for Quest Diagnostics Inc. > News item
Published on 4/15/2009 in the Prospect News Investment Grade Daily.

Moody's: Quest unaffected

Moody's Investors Service said Quest Diagnostics, Inc.'s Baa3 rating is unaffected by its settlement in the NID investigation for $302 million and $200 million share repurchase on March 19.

The outlook is stable.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.